These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5277695)

  • 1. Oral surgical treatment of patients with hemophilia "A", treated by cryoprecipitated factor 8.
    Shteyer A; Hershko A; Azaz B
    Refuat Hapeh Vehashinayim; 1970; 19():27-30. PubMed ID: 5277695
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryoprecipitated factor 8 concentrate.
    Pool JG
    Bibl Haematol; 1970; 34():23-9. PubMed ID: 5436350
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood products used in the treatment of hemophilia.
    Krasnoff AR; Mangione RA
    Hosp Pharm; 1982 Nov; 17(11):598-9, 602-4. PubMed ID: 10318549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo recovery of cryoprecipitated factor 8.
    Verstraete M; Lust A; Vermylen J
    Bibl Haematol; 1970; 34():9-17. PubMed ID: 5436359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
    Ollendorff P
    Ugeskr Laeger; 1969 May; 131(20):877-81. PubMed ID: 5795169
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of intraligamentary anesthesia in a patient with severe hemophilia and factor VIII inhibitor.
    Eigner TL
    Spec Care Dentist; 1990; 10(4):121-4. PubMed ID: 11100219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
    Schwartz RS; Abildgaard CF; Aledort LM; Arkin S; Bloom AL; Brackmann HH; Brettler DB; Fukui H; Hilgartner MW; Inwood MJ
    N Engl J Med; 1990 Dec; 323(26):1800-5. PubMed ID: 2123300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appendectomy in hemophilia with the use of cryoprecipitated human factor 8 to control bleeding.
    Schwartz JM; Cohn BD; Ritz ND; Levy T
    JAMA; 1966 Dec; 198(11):1175-9. PubMed ID: 5953498
    [No Abstract]   [Full Text] [Related]  

  • 9. Dental management of hemophiliac child under general anesthesia.
    Rayen R; Hariharan VS; Elavazhagan N; Kamalendran N; Varadarajan R
    J Indian Soc Pedod Prev Dent; 2011; 29(1):74-9. PubMed ID: 21521925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of factor 8 rich cryoproteins in the treatment of hemophilia].
    Vergoz D; Combrisson A; Vialette T; André R
    Transfusion (Paris); 1967; 10(1):3-10. PubMed ID: 6048649
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preventive treatment with antihemophilic globulin concentrates of animal origin in 2 hemophilic patients undergoing surgery].
    d' Auteuil P; Sirois M
    Union Med Can; 1966 Jun; 95(6):695-700. PubMed ID: 5936513
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current approach to hemophilia.
    Morrison CJ
    J Maine Med Assoc; 1974 Sep; 65(9):205-6. PubMed ID: 4416140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral administration of factor VIII or IX concentrate preparation].
    Sakuragawa N
    Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721
    [No Abstract]   [Full Text] [Related]  

  • 16. [Advances in prophylaxis, therapy and surgical procedures in patients with hemophilia A].
    Rudowski W
    Przegl Lek; 1973; 30(6):489-93. PubMed ID: 4732443
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
    Kunst VA; Nováková IR; Haanen C
    Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1163-6. PubMed ID: 2501689
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.